Tratamiento farmacológico del glaucoma de ángulo abierto

  1. José Manuel Martínez Sesmero
  2. A. Solórzano Martín
  3. A. Cruz Martos
  4. T. Molina García
  5. C. Montojo Guillén
Revista:
Atención Farmacéutica

ISSN: 1139-7357

Año de publicación: 2005

Volumen: 7

Número: 1

Páginas: 40-43

Tipo: Artículo

Otras publicaciones en: Atención Farmacéutica

Resumen

Glaucoma is characterized by a progressive injury of the optical nerve, whose main risk factor is the increase in intraocular pressure (IOP). The risk factors considered for presenting glaucoma are high IOP, age (infrequent in <40 years), black race (prevalence 4-16 times higher than in the white race), family history of glaucoma, myopia, diabetes, arterial hypertension and/or hypotension. Among the different types of glaucoma, the open-angle primary one represents 80-90% of the total cases. The purpose of our revision is to evaluate the criteria for selecting a specific medication, based on patient's general history, tolerance and both general and local adverse effects